LSE - Delayed Quote USD
Eastman Chemical Company (0IF3.L)
76.98
+0.79
+(1.04%)
At close: 6:01:10 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 15 | 17 |
| Avg. Estimate | 2.32B | 2.44B | 9.28B | 9.63B |
| Low Estimate | 2.25B | 2.4B | 8.98B | 8.97B |
| High Estimate | 2.38B | 2.51B | 9.45B | 10.04B |
| Year Ago Sales | 2.36B | 2.46B | 9.38B | 9.28B |
| Sales Growth (year/est) | -1.94% | -0.89% | -1.08% | 3.73% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0IF3.L | -- | -- | -- | -- |
| S&P 500 | 10.31% | 3.92% | 8.21% | 13.85% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/29/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 4/28/2025 |
| Maintains | Keybanc: Overweight to Overweight | 4/28/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 4/28/2025 |
| Downgrade | JP Morgan: Overweight to Neutral | 4/28/2025 |
| Maintains | Keybanc: Overweight to Overweight | 4/14/2025 |